Moderna Therapeutics is working in association with Amazon’s cloud service to deliver a new class of medicines that apply messenger RNA (mRNA). The mRNA is called the software of life. The bio-tech company is conducting clinical trials with mRNA, a single stranded molecule used to make protein in cells.
In an interview with CNBC, Stephane Bancel, CEO of the company explained how Amazon Web Services is playing a central role in the research to create medicines for infectious and rare diseases, and cancer.
Moderna is using Amazon’s loud platform for more than a dozen drug candidates in the pipeline, with seven going through trial studies. The cloud service s used to help speed up the amount if time it takes to get the drugs from research to clinical trials.